Grace Blest-Hopley, PhD, is a researcher investigating cannabis, cannabinoids, and psychedelics’ neurochemical and neurofunctional aspects. As Chief Scientific Officer at NW Pharma Tech, she leads clinical trials in psychiatric and neurological disorders. With a focus on large-scale data-driven research, she collaborates with Heroic Hearts to explore psychedelic substances’ therapeutic potential for combat trauma. Blest-Hopley also works as a Post Doctoral Researcher at King’s College London.